vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Fabrinet (FN). Click either name above to swap in a different company.
Fabrinet is the larger business by last-quarter revenue ($1.1B vs $821.5M, roughly 1.4× Acadia Healthcare Company, Inc.). Fabrinet runs the higher net margin — 9.9% vs -143.3%, a 153.3% gap on every dollar of revenue. On growth, Fabrinet posted the faster year-over-year revenue change (35.9% vs 6.1%). Fabrinet produced more free cash flow last quarter ($-5.3M vs $-179.5M). Over the past eight quarters, Fabrinet's revenue compounded faster (24.4% CAGR vs 3.4%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
FabrinetFNEarnings & Financial Report
Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.
ACHC vs FN — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $1.1B |
| Net Profit | $-1.2B | $112.6M |
| Gross Margin | — | 12.2% |
| Operating Margin | -142.4% | 10.1% |
| Net Margin | -143.3% | 9.9% |
| Revenue YoY | 6.1% | 35.9% |
| Net Profit YoY | -3710.4% | 30.0% |
| EPS (diluted) | $-12.98 | $3.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $1.1B | ||
| Q3 25 | $851.6M | $978.1M | ||
| Q2 25 | $869.2M | $909.7M | ||
| Q1 25 | $770.5M | $871.8M | ||
| Q4 24 | $774.2M | $833.6M | ||
| Q3 24 | $815.6M | $804.2M | ||
| Q2 24 | $796.0M | $753.3M | ||
| Q1 24 | $768.1M | $731.5M |
| Q4 25 | $-1.2B | $112.6M | ||
| Q3 25 | $36.2M | $95.9M | ||
| Q2 25 | $30.1M | $87.2M | ||
| Q1 25 | $8.4M | $81.3M | ||
| Q4 24 | $32.6M | $86.6M | ||
| Q3 24 | $68.1M | $77.4M | ||
| Q2 24 | $78.5M | $81.1M | ||
| Q1 24 | $76.4M | $80.9M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | -142.4% | 10.1% | ||
| Q3 25 | 4.7% | 9.6% | ||
| Q2 25 | 5.8% | 9.8% | ||
| Q1 25 | 1.7% | 9.0% | ||
| Q4 24 | 4.9% | 9.5% | ||
| Q3 24 | 12.1% | 9.6% | ||
| Q2 24 | 13.4% | 9.7% | ||
| Q1 24 | 12.9% | 9.7% |
| Q4 25 | -143.3% | 9.9% | ||
| Q3 25 | 4.3% | 9.8% | ||
| Q2 25 | 3.5% | 9.6% | ||
| Q1 25 | 1.1% | 9.3% | ||
| Q4 24 | 4.2% | 10.4% | ||
| Q3 24 | 8.4% | 9.6% | ||
| Q2 24 | 9.9% | 10.8% | ||
| Q1 24 | 9.9% | 11.1% |
| Q4 25 | $-12.98 | $3.11 | ||
| Q3 25 | $0.40 | $2.66 | ||
| Q2 25 | $0.33 | $2.41 | ||
| Q1 25 | $0.09 | $2.25 | ||
| Q4 24 | $0.36 | $2.38 | ||
| Q3 24 | $0.74 | $2.13 | ||
| Q2 24 | $0.85 | $2.22 | ||
| Q1 24 | $0.83 | $2.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $960.8M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $1.9B | $2.2B |
| Total Assets | $5.5B | $3.3B |
| Debt / EquityLower = less leverage | 1.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $960.8M | ||
| Q3 25 | $118.7M | $968.8M | ||
| Q2 25 | $131.4M | $934.2M | ||
| Q1 25 | $91.2M | $950.7M | ||
| Q4 24 | $76.3M | $934.6M | ||
| Q3 24 | $82.1M | $908.9M | ||
| Q2 24 | $77.2M | $858.6M | ||
| Q1 24 | $77.3M | $794.0M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | $2.0B | ||
| Q1 25 | $3.0B | $1.9B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | $1.7B | ||
| Q1 24 | $2.9B | $1.7B |
| Q4 25 | $5.5B | $3.3B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $2.8B | ||
| Q1 25 | $6.1B | $2.6B | ||
| Q4 24 | $6.0B | $2.5B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $5.7B | $2.3B | ||
| Q1 24 | $5.5B | $2.2B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $46.3M |
| Free Cash FlowOCF − Capex | $-179.5M | $-5.3M |
| FCF MarginFCF / Revenue | -21.8% | -0.5% |
| Capex IntensityCapex / Revenue | 11.3% | 4.6% |
| Cash ConversionOCF / Net Profit | — | 0.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | $102.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $46.3M | ||
| Q3 25 | $73.2M | $102.6M | ||
| Q2 25 | $133.5M | $55.1M | ||
| Q1 25 | $11.5M | $74.2M | ||
| Q4 24 | $116.7M | $115.9M | ||
| Q3 24 | $163.1M | $83.2M | ||
| Q2 24 | $171.1M | $83.1M | ||
| Q1 24 | $-321.3M | $100.9M |
| Q4 25 | $-179.5M | $-5.3M | ||
| Q3 25 | $-63.0M | $57.3M | ||
| Q2 25 | $-34.2M | $4.7M | ||
| Q1 25 | $-163.2M | $45.7M | ||
| Q4 24 | $-86.8M | $94.0M | ||
| Q3 24 | $-27.1M | $62.9M | ||
| Q2 24 | $16.9M | $70.4M | ||
| Q1 24 | $-463.7M | $87.3M |
| Q4 25 | -21.8% | -0.5% | ||
| Q3 25 | -7.4% | 5.9% | ||
| Q2 25 | -3.9% | 0.5% | ||
| Q1 25 | -21.2% | 5.2% | ||
| Q4 24 | -11.2% | 11.3% | ||
| Q3 24 | -3.3% | 7.8% | ||
| Q2 24 | 2.1% | 9.3% | ||
| Q1 24 | -60.4% | 11.9% |
| Q4 25 | 11.3% | 4.6% | ||
| Q3 25 | 16.0% | 4.6% | ||
| Q2 25 | 19.3% | 5.5% | ||
| Q1 25 | 22.7% | 3.3% | ||
| Q4 24 | 26.3% | 2.6% | ||
| Q3 24 | 23.3% | 2.5% | ||
| Q2 24 | 19.4% | 1.7% | ||
| Q1 24 | 18.5% | 1.9% |
| Q4 25 | — | 0.41× | ||
| Q3 25 | 2.02× | 1.07× | ||
| Q2 25 | 4.43× | 0.63× | ||
| Q1 25 | 1.37× | 0.91× | ||
| Q4 24 | 3.58× | 1.34× | ||
| Q3 24 | 2.39× | 1.07× | ||
| Q2 24 | 2.18× | 1.02× | ||
| Q1 24 | -4.21× | 1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
